Does neuropsychological test performance predict outcome of cognitive behavior therapy for Chronic Fatigue Syndrome and what is the role of underperformance? — CFSMEATLAS
Does neuropsychological test performance predict outcome of cognitive behavior therapy for Chronic Fatigue Syndrome and what is the role of underperformance?
Goedendorp, Martine M, van der Werf, Sieberen P, Bleijenberg, Gijs et al. · Journal of psychosomatic research · 2013 · DOI
Quick Summary
This study looked at whether cognitive impairments (problems with thinking and memory) measured by tests could predict how well patients would improve with cognitive behavior therapy (CBT) for ME/CFS. Researchers also examined whether some patients might be doing poorly on tests due to not trying their best, rather than actual cognitive problems. The study found that while some patients did perform worse on these tests, this didn't predict whether CBT would help reduce fatigue or improve daily functioning—though patients who weren't trying their best were more likely to drop out of treatment.
Why It Matters
Understanding which cognitive factors predict CBT response is crucial for personalizing ME/CFS treatment and setting realistic expectations. This study suggests that poor test performance alone should not exclude patients from CBT, but that motivational and psychological factors underlying underperformance warrant clinical attention to reduce treatment abandonment.
Observed Findings
Underperformance on cognitive testing was associated with worse neuropsychological test performance overall.
Underperformance was significantly associated with higher dropout rates from CBT treatment.
Neither underperformance nor neuropsychological test performance predicted changes in fatigue severity following CBT.
Neither underperformance nor neuropsychological test performance predicted changes in functional impairments or physical limitations following CBT.
Patients who showed poor effort on testing did not differ in fatigue improvement compared to others, despite dropping out more frequently.
Inferred Conclusions
Poor cognitive test performance or effort does not necessarily indicate poor prognosis for CBT outcomes in fatigue, functional impairment, or physical limitations.
Underperformance is a distinct clinical issue associated with dropout risk, potentially reflecting motivational, behavioral, or environmental factors separate from cognitive ability.
Therapists should assess and address beliefs and behavioral factors maintaining underperformance, as this may reduce treatment discontinuation.
Remaining Questions
What specific beliefs, behavioral patterns, or environmental factors maintain underperformance in ME/CFS patients, and how can these be addressed to reduce dropout?
What This Study Does Not Prove
This study does not prove that cognitive impairments cause treatment failure or that poor test performance is purely motivational. The research cannot establish causation—underperformance and dropout may both result from third factors like symptom severity or psychological distress, rather than underperformance causing dropout. Results may not generalize to ME/CFS populations in other countries or treatment settings.
Does actual cognitive impairment (distinct from underperformance) exist in ME/CFS patients, and if so, does it respond to alternative treatment approaches?
Are there baseline characteristics (symptom severity, mood, illness beliefs) that differentiate underperforming patients who drop out from those who complete treatment?